The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1S,2R)-2-(6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)cyclopentyl)acrylamide ID: ALA4793510
PubChem CID: 162672834
Max Phase: Preclinical
Molecular Formula: C24H25Cl2N5O4
Molecular Weight: 518.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N[C@H]1CCC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1
Standard InChI: InChI=1S/C24H25Cl2N5O4/c1-5-18(32)28-14-7-6-8-15(14)29-24-27-11-12-9-13(23(33)31(2)22(12)30-24)19-20(25)16(34-3)10-17(35-4)21(19)26/h5,9-11,14-15H,1,6-8H2,2-4H3,(H,28,32)(H,27,29,30)/t14-,15+/m0/s1
Standard InChI Key: PJEPTYCBAHFMAA-LSDHHAIUSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
8.9299 -10.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9288 -11.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6409 -12.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3547 -11.6324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3519 -10.8056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6391 -10.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2201 -12.0427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5129 -11.6273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5094 -13.2689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2256 -12.8627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7980 -12.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8066 -12.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1023 -11.6216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3889 -12.0263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3843 -12.8483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0892 -13.2577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6367 -9.5790 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3473 -9.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0672 -12.0440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0685 -12.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6407 -12.8672 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.2180 -10.4007 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.9325 -13.2726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5059 -14.0903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6702 -13.2531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9606 -12.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8784 -12.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0758 -11.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6634 -12.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2070 -13.1675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0320 -13.9699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2490 -14.2174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0740 -15.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2910 -15.2714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6411 -13.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 10 1 0
8 12 1 0
11 9 1 0
9 10 1 0
2 7 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
6 17 1 0
17 18 1 0
4 19 1 0
19 20 1 0
3 21 1 0
1 22 1 0
10 23 2 0
9 24 1 0
15 25 1 0
26 25 1 1
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 26 1 0
30 31 1 1
31 32 1 0
32 33 1 0
33 34 2 0
32 35 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.40Molecular Weight (Monoisotopic): 517.1284AlogP: 3.95#Rotatable Bonds: 7Polar Surface Area: 107.37Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.69CX LogP: 3.59CX LogD: 3.59Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.46Np Likeness Score: -0.20
References 1. Liu H,Niu D,Tham Sjin RT,Dubrovskiy A,Zhu Z,McDonald JJ,Fahnoe K,Wang Z,Munson M,Scholte A,Barrague M,Fitzgerald M,Liu J,Kothe M,Sun F,Murtie J,Ge J,Rocnik J,Harvey D,Ospina B,Perron K,Zheng G,Shehu E,D'Agostino LA. (2020) Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma., 11 (10): [PMID:33062171 ] [10.1021/acsmedchemlett.9b00601 ]